El Blog de noticias sobre Derecho Anglo-Americano

El Gertrude Ryan Law Observatory ha creado un espacio dedicado al análisis y comentario de
temas de actualidad en el mundo jurídico de los Estados Unidos, orientado a promover y
fomentar la universalización del Derecho en todas sus áreas


martes, 20 de noviembre de 2007

The Wall Street Journal: Victoria judicial para Pfizer

Pfizer Legal Win Might BlockSome Lawsuits Over Celebrex

By NATHAN KOPPEL and HEATHER WON TESORIERONovember 20, 2007; Page A13
Pfizer Inc. scored a victory yesterday through a federal ruling that might wipe out some lawsuits alleging that the drug maker's painkiller Celebrex caused heart attacks and strokes.

U.S. District Judge Charles R. Breyer of San Francisco ruled that plaintiffs in the litigation haven't presented scientifically reliable evidence that Celebrex caused heart attacks or strokes when taken at a daily dosage of 200 milligrams. That is the most common dosage, according to Pfizer.

Celebrex is the last drug in the COX-2 inhibitor class that is sold in the U.S. Merck & Co.'s Vioxx and Pfizer's other COX-2 painkiller, Bextra, were withdrawn from the market amid safety concerns.

There are more than 3,000 Celebrex plaintiffs, according to the ruling, but it isn't clear how many the ruling will affect. Paul Sizemore, a plaintiffs' attorney with Girardi & Keese in Los Angeles, estimates that about 900 Celebrex cases involve plaintiffs who were prescribed the 200-milligram dose. However, he says, many of the plaintiffs took the drug twice a day.

"When does a 200-milligram case become a 400-milligram case?" he says. "We are going to have to review medical records and contact the clients to see what the actual usage was."

New York plaintiffs' lawyer Paul Pennock of Weitz & Luxenberg, which also handles Celebrex cases, estimates about two-thirds of the Celebrex cases will be unaffected by the ruling. But those involving 200-milligram dosages will be eliminated, he says.

"We are pleased with the decision of the federal court, which recognizes the lack of any credible evidence linking Celebrex, at its most common dosage form, with heart attacks or strokes," Pfizer General Counsel Allen Waxman said.

Write to Nathan Koppel at nathan.koppel@wsj.com and Heather Won Tesoriero at heather.tesoriero@wsj.com

The Wall Street Journal: Stock-Option Basckdating Scandal

Firms Settle Backdating Suits
Some Private CasesEnd in Agreements;More Deals Ahead?

By ASHBY JONESNovember 19, 2007; Page A15
Settlements have been reached in recent months on some private lawsuits arising from the stock-options backdating scandal, with several rendering relatively modest payouts compared with some class-action suits.

Several so-called derivative suits, the most common type of suit in the wake of the backdating revelations, have been settled under multipart arrangements in which executives pay back money to the company and companies make some changes to corporate governance and pay the fees of the plaintiffs' lawyers.

In September, executives and board members at Barnes & Noble Inc. agreed to a repricing of options worth $3 million and to a repayment of $2 million to the company, while the company consented to some 15 "therapeutics," or changes in governance, including an audit-committee review of stock-option internal controls at least once a year. The company agreed to pay plaintiffs' lawyers a $2.75 million fee. Recent settlements involving Sepracor Inc. and Family Dollar Stores Inc. involved similar three-tiered approaches.

Lawyers on both sides predict the settlements so far will pave the way for more. "The cases are likely going to start to fall," said Lee Rudy of Schiffrin, Barroway, Topaz & Kessler LLP, a plaintiffs' firm handling several dozen backdating cases.

Stock options allow recipients to buy stock at a preset exercise price, generally set at the market price on the day the options were granted. Backdating involves pretending that an option was granted on an earlier date when the market price was lower. The practice can lead to accounting irregularities and tax problems for the companies and executives involved.

The backdating scandal has led to more than 80 financial restatements, dozens of executive dismissals, and civil and criminal government investigations. In August, Gregory Reyes, the former head of Brocade Communications Systems Inc., was found guilty on criminal charges related to backdating. Recently, however, the Securities and Exchange Commission has ended several investigations without filing formal charges.

So far, plaintiffs' efforts involving backdating have met with mixed results. In typical securities-fraud class-action lawsuits, shareholders allege company executives misled investors; shareholders as a group sue after bad news triggers a drop in the share price. But because word of options backdating typically didn't lead to significant drops in share prices, only about 30 class-action lawsuits have been filed.

At least two suits have been dismissed partly for failure to properly allege that fraud led to a stock drop, including one this month involving Apple Inc. Still, a handful of class-action suits have been settled; one, involving Mercury Interactive Corp., settled for $117.5 million.

Mostly, plaintiffs' lawyers have filed "derivative suits," somewhat awkward creations in which shareholders sue a company (and others) on behalf of the company itself, alleging not personal but corporate losses. To date, more than 160 derivative cases have been filed, many brought by two firms, Schiffrin Barroway and Coughlin Stoia Geller Rudman & Robbins LLP.

More than a dozen derivative cases have been dismissed by courts. In those that have settled, the amounts paid out, both to the company and to the plaintiffs' lawyers, are relatively small. "In many cases, plaintiffs' lawyers are really just aiming to secure corporate therapeutics and, beyond that, just make a living," says Kevin LaCroix, a lawyer who focuses on issues of directors' and officers' liability and has had a limited role in some backdating cases.

In the Sepracor settlement, more than 2.2 million unexercised options were repriced and 500,000 were canceled. And in a settlement reached earlier this year between plaintiffs and Family Dollar, three executives and a director agreed to give up 210,000 options.
Write to Ashby Jones at ashby.jones@wsj.com

The New York Times: Opiniones secretas del Departamento de Justicia

Op-Ed Contributor
Release Justice’s Secrets

By NICHOLAS deB. KATZENBACH and FREDERICK A. O. SCHWARZ Jr.

MICHAEL MUKASEY has been confirmed as attorney general. But the profound moral, legal and constitutional issues raised at his Senate Judiciary Committee hearings are unresolved. Mr. Mukasey should open the door to their resolution by releasing the Justice Department’s long-secret legal opinions that have warped our fight against terrorism.

When the Justice Department, usually acting through its Office of Legal Counsel, issues legal opinions binding on the executive branch, there is never justification for keeping them secret.
Opinions that narrowly define what constitutes torture; or open the door to sending prisoners for questioning to Egypt and Syria, which regularly use torture; or rule the president has some “inherent power” to ignore laws are all of concern to Congress and the public whether one agrees or disagrees with the legal analysis.

Yet all these opinions have been kept secret, along with many other, related post-9/11 opinions that purport to decide what America’s law is.

Secrecy always increases the risk of foolish mistakes. If the withheld opinions are sound, why fear letting them see the light of day? Is there ever a justification in a government of law for keeping what one believes to be the law secret?

Some may say releasing the opinions will lead to more embarrassment. To this, there are two answers. First, what is most important is that we get it right and remain true to our country’s values. Second, the best way to restore our reputation is to confront our mistakes openly and then resolve not to repeat them.

Some also say that releasing opinions on, for example, torture, may give terrorists a window into what techniques we do and do not use. Again, this has it backwards. The world should know we reject the tactics of the enemy.

These issues must be faced openly by the new attorney general, by Congress, by presidential candidates and by the American public.

Mr. Mukasey can do a great deal to help restore both our Constitution and America’s reputation, and thus strengthen us at home and abroad. A good start would be to release the secret opinions of the Office of Legal Counsel.

Nicholas deB. Katzenbach was the United States attorney general from 1965 to 1966. Frederick A. O. Schwarz Jr. is the senior counsel at the Brennan Center for Justice at New York University.